238 related articles for article (PubMed ID: 7883578)
21. Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy.
Piwowar A; Knapik-Kordecka M; Szczecińska J; Warwas M
Diabetes Metab Res Rev; 2008 Oct; 24(7):549-53. PubMed ID: 18613218
[TBL] [Abstract][Full Text] [Related]
22. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy.
Moriwaki Y; Yamamoto T; Shibutani Y; Aoki E; Tsutsumi Z; Takahashi S; Okamura H; Koga M; Fukuchi M; Hada T
Metabolism; 2003 May; 52(5):605-8. PubMed ID: 12759891
[TBL] [Abstract][Full Text] [Related]
23. Diabetic microangiopathy and urinary glycosaminoglycans.
Kahaly G; Hansen C; Otto E; Förster G; Beyer J; Hommel G
Exp Clin Endocrinol Diabetes; 1997; 105(3):145-51. PubMed ID: 9228510
[TBL] [Abstract][Full Text] [Related]
24. Difference of serum levels of type IV collagen 7S between early or overt nephropathy and nondiabetic renal disease in diabetic patients with micro- or macroalbuminuria.
Inomata S; Itoh M; Sato T
Nephron; 1996; 73(4):601-5. PubMed ID: 8856258
[TBL] [Abstract][Full Text] [Related]
25. Clinical indicators which necessitate renal biopsy in type 2 diabetes mellitus patients with renal disease.
Lin YL; Peng SJ; Ferng SH; Tzen CY; Yang CS
Int J Clin Pract; 2009 Aug; 63(8):1167-76. PubMed ID: 18422591
[TBL] [Abstract][Full Text] [Related]
26. Significance of urinary type IV collagen in patients with diabetic nephropathy using a highly sensitive one-step sandwich enzyme immunoassay.
Yagame M; Suzuki D; Jinde K; Saotome N; Sato H; Noguchi M; Sakai H; Kuramoto T; Sekizuka K; Iijima T; Suzuki S; Tomino Y
J Clin Lab Anal; 1997; 11(2):110-6. PubMed ID: 9058245
[TBL] [Abstract][Full Text] [Related]
27. Asian multicenter trials on urinary type IV collagen in patients with diabetic nephropathy.
Tomino Y; Suzuki S; Azushima C; Shou I; Iijima T; Yagame M; Wang LN; Chen HC; Lai KN; Tan SY; Kim MJ
J Clin Lab Anal; 2001; 15(4):188-92. PubMed ID: 11436201
[TBL] [Abstract][Full Text] [Related]
28. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
Kacso IM; Bondor CI; Kacso G
Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
[TBL] [Abstract][Full Text] [Related]
29. Serum Angptl2 levels are independently associated with albuminuria in type 2 diabetes.
Li Q; Gong W; Yang Z; Lu B; Yang Y; Zhao W; Hu R
Diabetes Res Clin Pract; 2013 Jun; 100(3):385-90. PubMed ID: 23602322
[TBL] [Abstract][Full Text] [Related]
30. Multiplex bead analysis of urinary cytokines of type 2 diabetic patients with normo- and microalbuminuria.
Liu J; Zhao Z; Willcox MD; Xu B; Shi B
J Immunoassay Immunochem; 2010; 31(4):279-89. PubMed ID: 21113841
[TBL] [Abstract][Full Text] [Related]
31. Follow-up study on urinary type IV collagen in patients with early stage diabetic nephropathy.
Iijima T; Suzuki S; Sekizuka K; Hishiki T; Yagame M; Jinde K; Saotome N; Suzuki D; Sakai H; Tomino Y
J Clin Lab Anal; 1998; 12(6):378-82. PubMed ID: 9850190
[TBL] [Abstract][Full Text] [Related]
32. Intensive insulin therapy decreases urinary MCP-1 and ICAM-1 excretions in incipient diabetic nephropathy.
Ye SD; Zheng M; Zhao LL; Qian Y; Yao XM; Ren A; Li SM; Jing CY
Eur J Clin Invest; 2009 Nov; 39(11):980-5. PubMed ID: 19663918
[TBL] [Abstract][Full Text] [Related]
33. Lack of association between plasma homocysteine levels and microangiopathy in type 1 diabetes mellitus.
Agardh CD; Agardh E; Andersson A; Hultberg B
Scand J Clin Lab Invest; 1994 Dec; 54(8):637-41. PubMed ID: 7709167
[TBL] [Abstract][Full Text] [Related]
34. Plasma type IV collagen and fibronectin concentrations in diabetic patients with microangiopathy.
Lee IK; Park KY; Oh HK; Park RW; Jo JS
J Korean Med Sci; 1994 Aug; 9(4):341-6. PubMed ID: 7848583
[TBL] [Abstract][Full Text] [Related]
35. Serum type IV collagen in diabetic patients at risk for nephropathy.
Cohen MP; Shearman CW; Lautenslager GT
Diabetes Care; 2001 Aug; 24(8):1324-7. PubMed ID: 11473064
[TBL] [Abstract][Full Text] [Related]
36. A further investigation on a MALDI-based method for evaluation of markers of renal damage.
Lapolla A; Molin L; Sechi A; Cosma C; Ragazzi E; Seraglia R; Traldi P
J Mass Spectrom; 2009 Dec; 44(12):1754-60. PubMed ID: 19852035
[TBL] [Abstract][Full Text] [Related]
37. Glycemic control reverses increases in urinary excretions of immunoglobulin G and ceruloplasmin in type 2 diabetic patients with normoalbuminuria.
Narita T; Fujita H; Koshimura J; Meguro H; Kitazato H; Shimotomai T; Kagaya E; Suzuki K; Murata M; Usami A; Ito S
Horm Metab Res; 2001 Jun; 33(6):370-8. PubMed ID: 11456288
[TBL] [Abstract][Full Text] [Related]
38. Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria.
Wang ST; Xu JM; Wang M; Chen FL; Ding G
Clin Nephrol; 2013 Mar; 79(3):192-8. PubMed ID: 23073066
[TBL] [Abstract][Full Text] [Related]
39. Immunoglobulin G levels can predict non-diabetic renal disease in patients with type 2 diabetes mellitus.
Weng CH; Hu CC; Yu CC; Lin JL; Yang CW; Hung CC; Hsu CW; Yen TH
J Diabetes; 2012 Mar; 4(1):37-40. PubMed ID: 22145829
[TBL] [Abstract][Full Text] [Related]
40. Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentrations in Type 2 diabetic patients with microalbuminuria or macroalbuminuria.
Nakamura T; Ushiyama C; Suzuki S; Shimada N; Sekizuka K; Ebihara L; Koide H
Diabet Med; 2001 Apr; 18(4):308-13. PubMed ID: 11437862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
